Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6338)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2013 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liao XH, Cao X, Liu J, Xie XH, Sun YH, Zhong BH. Prevalence and features of fatty liver detected by physical examination in Guangzhou. World J Gastroenterol 2013; 19(32): 5334-5339 [PMID: 23983438 DOI: 10.3748/wjg.v19.i32.5334] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i32/5334.htm |
| Number | Citing Articles |
| 1 |
Umair Iqbal, Brandon J. Perumpail, Daud Akhtar, Donghee Kim, Aijaz Ahmed. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. Medicines 2019; 6(1): 41 doi: 10.3390/medicines6010041
|
| 2 |
Yaohui Wang, Yuhua Zeng, Changwei Lin, Zhiheng Chen. Hypertension and non‐alcoholic fatty liver disease proven by transient elastography. Hepatology Research 2016; 46(13): 1304 doi: 10.1111/hepr.12688
|
| 3 |
Min Zhang, Man-Li Hu, Jiao-Jiao Huang, San-Shan Xia, Yan Yang, Kun Dong. Association of leukocyte telomere length with non-alcoholic fatty liver disease in patients with type 2 diabetes. Chinese Medical Journal 2019; 132(24): 2927 doi: 10.1097/CM9.0000000000000559
|
| 4 |
Martins Ekor, Phyllis Elsie Owusu Agyei, Ernest Obese, Robert Peter Biney, Isaac Tabiri Henneh, Meshack Antwi-Adjei, Ewura Seidu Yahaya, Gordon Amoakohene, Patrick Kafui Akakpo, Michael Bader. Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia. PLOS ONE 2021; 16(8): e0247735 doi: 10.1371/journal.pone.0247735
|
| 5 |
Wei Chen, YuJie Zhang, Weili Wu, Hui Yang, Wenxiu Huang. Machine learning-based predictive model for abdominal diseases using physical examination datasets. Computers in Biology and Medicine 2024; 173: 108249 doi: 10.1016/j.compbiomed.2024.108249
|
| 6 |
Karn Wijarnpreecha, Panadeekarn Panjawatanan, Natasorn Lekuthai, Charat Thongprayoon, Wisit Cheungpasitporn, Patompong Ungprasert. Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta‐analysis. Liver International 2017; 37(6): 906 doi: 10.1111/liv.13329
|
| 7 |
Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, Stefano Ballestri, Christopher D. Byrne, Stephen H. Caldwell, Helena Cortez-Pinto, Antonio Grieco, Mariana V. Machado, Luca Miele, Giovanni Targher. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Digestive and Liver Disease 2015; 47(12): 997 doi: 10.1016/j.dld.2015.08.004
|
| 8 |
Kolar Venkataravanappa Vineetha, Sorikunte Huchappa Anand, Kambathnahalli Paramashivaiah Suresh Babu. PREVALENCE OF FATTY LIVER AND ITS ASSOCIATION WITH HIGH TOTAL CHOLESTEROL IN PEOPLE OF TUMKUR, INDIA. Journal of Evolution of Medical and Dental Sciences 2017; 6(16): 1264 doi: 10.14260/Jemds/2017/275
|
| 9 |
Wei-Dong Li, Kun-Fa Fu, Gui-Mei Li, Yan-Shu Lian, Ai-Min Ren, Yun-Jue Chen, Jin-Rong Xia. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus. World Journal of Gastroenterology 2015; 21(32): 9607-9613 doi: 10.3748/wjg.v21.i32.9607
|
| 10 |
Juanwen Zhang, Ying Zhao, Chengfu Xu, Yani Hong, Huanle Lu, Jianping Wu, Yu Chen. Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. Scientific Reports 2014; 4(1) doi: 10.1038/srep05832
|
| 11 |
Qiao-Hua Qiao, Wen-Hua Zhu, Yun-Xian Yu, Fei-Fei Huang, Li-Ying Chen. Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population. Medicine 2017; 96(38): e7853 doi: 10.1097/MD.0000000000007853
|
| 12 |
Stergios Kechagias, Patrik Nasr, Julia Blomdahl, Mattias Ekstedt. Established and emerging factors affecting the progression of nonalcoholic fatty liver disease. Metabolism 2020; 111: 154183 doi: 10.1016/j.metabol.2020.154183
|
| 13 |
Chuang Li, Weiwei Kong, Lixia Kang, Tiehan Zhang, Weiqun Zhang, Weidong Wang. Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver disease. Journal of Medical Biochemistry 2021; 40(1): 86 doi: 10.5937/jomb0-24666
|
| 14 |
Li Zhu, Aikebaier Aili, Cheng Zhang, Aili Saiding, Kelimu Abudureyimu. Prevalence of and risk factors for gallstones in Uighur and Han Chinese. World Journal of Gastroenterology 2014; 20(40): 14942-14949 doi: 10.3748/wjg.v20.i40.14942
|
| 15 |
Dimitrios Oikonomou, Georgios Georgiopoulos, Vassiliki Katsi, Chris Kourek, Constantinos Tsioufis, Alexendra Alexopoulou, Evaggelia Koutli, Dimitrios Tousoulis. Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?. European Journal of Gastroenterology & Hepatology 2018; 30(9): 979 doi: 10.1097/MEG.0000000000001191
|
| 16 |
Ke Chen, Xu Chen, Hongliang Xue, Peiwen Zhang, Wanjun Fang, Xuechen Chen, Wenhua Ling. Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway. Food & Function 2019; 10(2): 814 doi: 10.1039/C8FO01236A
|
| 17 |
Yao-Wei Zhao, Jing Yang, Jie Niu, Tong Wang, Xin-Dan Liang, Yang Ren, Rui Wang, Isac Medeiros. Pharmacodynamic Evaluation of the Gexia Zhuyu Decoction in the Treatment of NAFLD and the Molecular Mechanism Underlying the TRPM4 Pathway Regulation. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/3364579
|
| 18 |
Zhen-Ya Lu, Zhou Shao, Ya-Li Li, Muhuyati Wulasihan, Xin-Hua Chen. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study. World Journal of Gastroenterology 2016; 22(13): 3663-3669 doi: 10.3748/wjg.v22.i13.3663
|